SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-20-137446
Filing Date
2020-12-18
Accepted
2020-12-18 16:33:41
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2038778d1_s3.htm S-3 378389
2 EXHIBIT 1.2 tm2038778d1_ex1-2.htm EX-1.2 251204
3 EXHIBIT 4.2 tm2038778d1_ex4-2.htm EX-4.2 351046
4 EXHIBIT 5.1 tm2038778d1_ex5-1.htm EX-5.1 29466
5 EXHIBIT 5.2 tm2038778d1_ex5-2.htm EX-5.2 6010
6 EXHIBIT 23.2 tm2038778d1_ex23-2.htm EX-23.2 2686
7 GRAPHIC tm2038778d1_s3img01.jpg GRAPHIC 13622
8 GRAPHIC tm2038778d1_s3img002.jpg GRAPHIC 15648
  Complete submission text file 0001104659-20-137446.txt   1060587
Mailing Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065
Business Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065 650-847-1919
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-3 | Act: 33 | File No.: 333-251498 | Film No.: 201401038
SIC: 2834 Pharmaceutical Preparations